Form D · Biotechnology
TechAccel, LLC
Overland Park, KS · CIK 0001801525
Offering snapshot reported Feb 6, 2020 · SEC filing
- Reported sold
- Yet to sell Offering amount: $15M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 6, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-359885
Source: Form D, filed Feb 6, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marty Bicknell | Director |
| Paul Debruce | Director |
| H. Jeffrey Dobbs | Director |
| Terry Dunn | Director |
| Greg Graves | Director |
| Michael Helmstetter | Director, Executive, Promoter |
| Cliff 66202 Illig | Director |
| Richard B. Myers | Director |
| Roshann S. Parris | Director |
| John Sherman | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6811 Shawnee Mission Pkwy, Suite 215
Overland Park, KS, 66202
Overland Park, KS, 66202